These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3940273)

  • 1. Local cerebral glucose utilisation following indoleamine- and piperazine-containing 5-hydroxytryptamine agonists.
    Grome JJ; Harper AM
    J Neurochem; 1986 Jan; 46(1):117-24. PubMed ID: 3940273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of quipazine on pre- and postsynaptic serotonin receptors: single cell studies in the rat CNS.
    Blier P; de Montigny C
    Neuropharmacology; 1983 Apr; 22(4):495-9. PubMed ID: 6856049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circling produced by serotonin and dopamine agonists in raphe lesioned rats: a serotonin model.
    Slater P
    Pharmacol Biochem Behav; 1980 Dec; 13(6):817-21. PubMed ID: 7193875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone alters the effects of LSD, DOM and quipazine on operant behavior of rats.
    Mokler DJ; Commissaris RL; Henck JW; Rech RH
    Pharmacol Biochem Behav; 1984 Sep; 21(3):333-7. PubMed ID: 6593750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of apomorphine hypothermia by drugs affecting brain 5-hydroxytryptamine function.
    Menon MK; Vivonia CA
    Eur J Pharmacol; 1981 Dec; 76(2-3):223-7. PubMed ID: 7333357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of LSD and 5-methyoxy-N,N,-dimethyltryptamine on the RNA synthesis in the cell nuclei of rat's brain].
    Uebelhack R; Belkner J; Seidel K
    Psychiatr Neurol Med Psychol (Leipz); 1979 Apr; 31(4):194-6. PubMed ID: 493424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin-like actions of quipazine and CPP on spinal motoneurones.
    Neuman RS; White SR
    Eur J Pharmacol; 1982 Jun; 81(1):49-56. PubMed ID: 7117370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the putative GABAergic agonists, muscimol and THIP, upon local cerebral glucose utilisation.
    Kelly PA; McCulloch J
    J Neurochem; 1982 Sep; 39(3):613-24. PubMed ID: 7097270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The actions of neuroleptic drugs and putative serotonin receptor antagonists on LSD and quipazine-induced reductions of brain 5-HIAA concentrations.
    Jacoby JH; Poulakos JJ
    J Pharm Pharmacol; 1977 Dec; 29(12):771-3. PubMed ID: 22629
    [No Abstract]   [Full Text] [Related]  

  • 11. Head twitches induced by LSD and quipazine: similarities and differences.
    Vetulani J; Bednarczyk B; Reichenberg K; Rokosz A
    Neuropharmacology; 1980 Feb; 19(2):155-8. PubMed ID: 6244515
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute and chronic effects of LSD and 5-MeODMT on raphe-evoked dorsal root potentials in the cat.
    Larson AA
    Life Sci; 1984 Mar; 34(12):1193-201. PubMed ID: 6708724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin1c receptor reserve in choroid plexus masks receptor subsensitivity.
    Sanders-Bush E; Breeding M
    J Pharmacol Exp Ther; 1990 Mar; 252(3):984-8. PubMed ID: 2319481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon.
    Walker EA; Yamamoto T; Hollingsworth PJ; Smith CB; Woods JH
    J Pharmacol Exp Ther; 1991 Nov; 259(2):772-82. PubMed ID: 1941625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of quipazine and LSD on monoamines in the rat striatum.
    Miśkiewicz M; Rokosz-Pelc A; Vetulani J
    Pol J Pharmacol Pharm; 1979; 31(5):489-92. PubMed ID: 94944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biphasic effect of 5-methoxy-N,N-dimethyltryptamine on rat prolactin secretion.
    Simonovic M; Meltzer HY
    Brain Res; 1983 Aug; 272(2):269-75. PubMed ID: 6616203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological profile of a model for central serotonin receptor activation.
    Matthews WD; Smith CD
    Life Sci; 1980 Apr; 26(17):1397-403. PubMed ID: 6247593
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.
    Newton RA; Phipps SL; Flanigan TP; Newberry NR; Carey JE; Kumar C; McDonald B; Chen C; Elliott JM
    J Neurochem; 1996 Dec; 67(6):2521-31. PubMed ID: 8931486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-dependency of the pressor responses to selective 5-hydroxytryptamine receptor agonists in pithed rats.
    Kalkman HO; Boddeke HW; Timmermans PB; Van Zwieten PA
    J Auton Pharmacol; 1983 Dec; 3(4):281-6. PubMed ID: 6582064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.